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Summary 
Pluripotent lymphohematopoietic stem cells are probably confined to bone marrow cells expressing 
CD34 surface molecules. To investigate the capacity of adult human CD34 § bone marrow cells 
to differentiate  along the T  lymphoid lineage,  we plated  purified CD34 + cells  from healthy 
adults  in  liquid  culture  on  adherent  thymic  stromal  cells  prepared  from  HLA-  or  blood 
group-mismatched postnatal thymic tissue. We show that purified CD34 +  CD3-CD4-CD8- 
bone marrow cells contained progenitors with the ability to differentiate into CD4 + and CD8 + 
T  lymphocytes expressing surface (s)CD3 and T  cell receptor ot//~ in vitro. These progenitors 
were found in the CD34 +  CD2 + sCD3 - CD4- CD8 -,  CD34 +  CD7 + sCD3 - CD4 - CD8 -,  and 
CD34 +  CD2 § CD7 + sCD3- CD4- CDS-, as well as in the CD34 + CD2- sCD3- CD4- CD8-, 
CD34 +  CD7- sCD3- CD4- CD8-,  and CD34 +  CD2- CD7- sCD3- CD4- CD8-  subsets, indi- 
cating that  T  lymphocyte progenitors sensitive to signals mediated by thymic stroma in vitro 
are not restricted to CD34 + cells already coexpressing early T  lymphocyte-associated markers. 
Finally,  we show that  T  lymphopoiesis was enhanced by c-kit ligand. 
B 
one marrow cells expressing CD34 surface molecules con- 
stitute "~1% of low density nucleated bone marrow cells 
(1).  There are several observations to suggest  that  CD34 § 
cells include pluripotent  stem cells (2-12).  In mice, T  lym- 
phopoiesis can be demonstrated by transfer of bone marrow 
cells into irradiated  hosts, and differentiation to mature human 
T  lymphocytes from liver-derived fetal hematopoietic pro- 
genitors is observed in the Thy SCID-human  (hu) 1 mouse 
(13-16). Recently, P6ault et al. (17) have succeeded in recon- 
stituting T lymphopoiesis in fetal thymus in SCID-hu mice 
with fetal human CD34 + cells. In these experiments T lym- 
phocyte differentiation was accomplished in thymus in vivo. 
Maintenance of the thymic microenvironment has been claimed 
to be a prerequisite for differentiation of stem cells into ma- 
ture  T  lymphocytes (17). 
The aim of this  study was to investigate whether post- 
natal  human  CD34 §  bone marrow  cells  can  give rise  to 
T  lymphocyte  differentiation  in  vitro,  and  whether  full 
differentiation to mature T lymphocytes can be accomplished. 
This study shows that when cultured on thymic stroma,  a 
population of human CD34 + bone marrow cells devoid of 
the surface (s) molecules CD3, CD4, and CD8 can be directed 
into T lymphopoiesis in vitro, as ascertained by the appearance 
of cells expressing CD3, CD4, CDS, and TCR ot/~ surface 
1 Abbreviations used in tkis  paper: CM, complete medium; hu, human; rm, 
recombinant murine; s, surface. 
molecules after culture.  We also present data showing that 
the T  lymphocyte progenitors  are present  among CD34 + 
cells expressing the T  lymphocyte-associated markers CD2 
and/or CD7, as well as among CD34 § cells devoid of these 
markers.  Furthermore,  we show that  the growth ability of 
CD34 +  cells  is  significantly  enhanced  by  c-kit  ligand 
without  changing  the phenotypic profile of the progeny. 
Materials and Methods 
Cell Donors and Cell Preparation.  Bone marrow samples were 
obtained by aspiration from consenting healthy adults. Mononuclear 
cells were prepared by density gradient centrifugation (1.077 g/ml, 
Lymphoprep; Nycomed Pharma,  Oslo, Norway), washed twice, 
and resuspended in IMDM (Flow Laboratories, Irvine, Scotland) 
with  10%  (vol/vol)  FCS (Gibco,  Paisley, Scotland),  glutamine 
(2 mmol/liter;  Gibco), penicillin (60/zg/ml), and streptomycin (100 
/~g/ml), referred to as complete medium (CM). CD34 + cells were 
isolated with Dynabeads M-450 coupled with a mAb against CD34 
(BI-3CS) (Dynal, Oslo, Norway) as previously described (18, 19). 
Contaminating  mature  B lymphocytes  (CD34- CD19 §  CD37 § 
but not mature T lymphocytes (CD34-sCD3+CD4 § or CD34- 
sCD3+CD8 +) can be demonstrated among isolated CD34 + bone 
marrow cells (19). To increase the purity of the isolated CD34 § 
calls to )'95% to minimize the possibility of outgrowth of con- 
taminating T lymphocytes to account for the appearance of CD4 + 
and CD8 + cells after culture,  immunomagnetic  depletion  with 
Dynabeads M-450 coupled with mAbs against CD4, CD8, and 
CD19  (Dynal) was performed  (20). 
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mo of age undergoing median sternotomy and corrective cardio- 
vascular surgery (kindly provided by H. Lindberg, Surgical Depart- 
ment A, The National Hospital, Oslo, Norway). One donor was 
HLA-A2+,AKh +,  and  the  other  was  HLA-A2-,ORh + .  The 
thymic tissue was transported to the laboratory in HBSS (Gibco) 
with penicillin  and streptomycin. The thymic tissue was minced 
into pieces, and single cells were eluted in HBSS with collagenase 
(0.5  mg/ml) (Sigma  Chemical Co., St. Louis,  MO) and DNase 
I  (1  /~g/ml)  (Sigma  Chemical Co.)  at  37~  under continuous 
shaking for 1.5 h. After six to eight repeated cycles of elution the 
thymic tissue was totally disintegrated.  Single cell suspensions from 
the last three to four eluates were washed twice and resuspended 
in RPMI  1640 (Gibco) with penicillin  and streptomycin before 
cryopreservation. 
Antibodies.  The following mAbs were used for flow cytometry: 
FITC-labeled anti-Leu-Sb (CD2),  anti-Leu-4 (CD3),  anti-Leu-9 
(CD7),  and anti-HPCA-2  (8G12,  CD34),  and PE-labeled  anti- 
HPCA-2, anti-Leu-M7 (CD13), Simultest  CD4/CD8 (anti-Leu-3a 
FITC +  anti-Leu-2a PE), Simultest LeukoGATE (anti-HLe-1 FITC 
+  anti-Leu-M3 PE), and Simultest control (IgG1 FITC +  IgG2a 
PE) (Becton Dickinson Immunocytometry Systems [BDIS], Moun- 
tain View, CA). PE-labeled anti-CD2, and anti-CD34 (ICH3) were 
purchased from Caltag Laboratories, Inc. (South San Francisco, CA), 
anti-TCK o~/~ (BMA031) from Behringwerke AG (Marburg, Ger- 
many), and anti-CD3 (101.1) from Novo Research Institute (Copen- 
hagen, Denmark). Anti-HLA-A2 (ITI-8G12) was developed in our 
own laboratory by G. Gaudernack. Anti-A (blood group A) was 
purchased from Lorne Laboratories Ltd. (England). FITC-labeled 
anti-Leu-Sb and anti-Leu-9 and PE-labeled anti-HPCA-2 from BDIS 
were used for cell sorting by flow cytometry. The following mAbs 
were used for immunoftuorescence: TE-7, reactive with nonker- 
atinized, mesodermal-derived thymic fibrous stroma, and TE-15, 
reactive with Hassell's bodies (a kind gift from K. H. Singer, Duke 
University School of Medicine, Durham, NC) (21). Fluoresceinated 
goat anti-mouse isotype- and subclass-specific polyclonal antibodies 
were purchased  from  Southern Biotechnology Associates,  Inc. 
(Birmingham, AL). 
Culture Assays.  After thawing, eluted thymic cells were washed 
twice, resuspended in CM,  and plated, with 2  x  106 cells/well 
in 24-well tissue culture plates (Costar, Cambridge, MA). The cells 
were cultured in a humidified atmosphere of 5% CO2 in air at 
37~  for 6-8 d to establish a confluent layer of adherent cells. Su- 
pernatants were collected, filtered, and frozen for later use. Nonad- 
herent cells were removed from the wells by repeated washing. 
CD34 § cells were plated on the adherent thymic stromal cells, 
with 10  s cells/well in 1 ml CM with 10% (vol/vol) thymic stromal 
cell supernatant, and with four to five wells per series. The cells 
were cultured in the absence or presence of recombinant murine 
(rm) c-kit ligand (2 U/ml) (a kind gift from S. C. Clark, Genetics 
Institutes, Cambridge, MA). Media were half changed with fresh 
supernatant media twice weekly, rmc-kit ligand was added according 
to protocol. Nonadherent cells were harvested after 14 and 28 d, 
enumerated in a B/irker chamber, and analyzed by flow cytometry. 
To more closely identify prethymic T lymphocyte progenitors, 
flow  cytometry-sorted  CD34+CD2 +,  CD34+CD7 +,  CD34 + 
CD2+CD7 +,  CD34§  -,  CD34+CD7 -,  and CD34+CD2 - 
CD7-  cells  (2,500--5,000  cells/well)  were  cultured  on  thymic 
stromal cells in the presence of rmc-kit ligand, with two to three 
wells per series. Nonadherent cells were harvested, enumerated, 
and phenotyped by flow cytometry after 21 d. 
Bone marrow cells from the nonCD34 + fraction (i.e.,  bone 
marrow  cells  not  rosetting  with  BI-3C5-coated  Dynabeads), 
CD4 § T  lymphocytes, or CD8 § T  lymphocytes (10  s cells/well) 
were also cultured under the same conditions. To study the neces- 
sity of thymic stroma to support T lymphopoiesis, adherent cells 
prepared from MRC-5 (a flbroblast cell line), Hep-2 (a hepatoma 
cell line), and allogeneic peripheral blood monocytes, and nonad- 
herent allogeneic Epstein-Barr blasts were substituted for thymic 
stromal cells. Furthermore, CD34 + cells were cultured in 96-well 
U-bottomed tissue culture plates  (Costar), with 1,000 cells/well 
in 200/zl CM, in the presence of  irradiated allogeneic PBMC, PHA 
(1/zg/ml) (Wdcome, Dartford, England), and rlL-2 (10 U/ml) (Gen- 
zyme, Cambridge, MA). The cultures were restimulated with ir- 
radiated allogeneic PBMC, PHA, and rib2 after 7 d and cultured 
for an additional 8 d. The cells were cultured for the last  18 h in 
the presence of 10/zM [3H]thymidine (2 Ci/mmol), harvested on 
filter mats, and counted using a scintillation counter (LKB Instru- 
ments,  Turku,  Finland).  Non-CD34 §  bone  marrow  cells  and 
PBMC served as positive controls, and irradiated PBMC served as 
negative control. 
Flow Cytometry and Cell Sorting.  Cell staining was performed 
according to the manufacturer's instructions and the cells were 
resuspended in HBSS with 1% paraformaldehyde.  Flow cytometry 
analyses were performed on a FACScan  |  with the FACScan  |  Re- 
search Software (BDIS). 50,000 events were acquired and stored 
in list mode files. 
Cell sorting was performed on an Epics Elite (Coulter Electronics, 
Hialeah, FL). Cells were sorted at a rate of 800-1,000 cells/s. A 
sort gate within a dual parameter cytogram of forward light scatter 
against 90  ~ side scatter was drawn. A second amorphous gate was 
drawn on the two-color cytograms shown (Fig. 6). Sort equations 
were set to positively sort cells satisfying  both gates. 
Immunofluorescence Microscopy.  To investigate the identity of the 
adherent cell layer, the adherent cells were fixed in ethanol, in- 
cubated with the mAbs for 30 min at room temperature, washed 
twice, and incubated with a goat anti-mouse fluoresceinated  an- 
tibody. 
Limiting  Dilution Assays.  To examine the T  lymphocyte pre- 
cursor frequency of CD34 + cells expressing the CD2 and CD7 
markers and CD34 + cells devoid of these markers, we performed 
experiments in limiting dilution assays. Allogeneic adherent thymic 
stromal cells were established in 96-well flat-bottomed tissue cultures 
plates (Costar) as described above. CD34+CD2 ~, CD34+CD7 +, 
CD34+CD2 -, and CD34+CD7 -  cells were plated with CM sup- 
plemented with rmc-kit ligand (2 U/ml) and 10% (vol/vol) thymic 
stromal cell supernatant at 15-240 cells/well with 20 replicates per 
concentration. Media were doubled at day 5 and then half changed 
with fresh rmc-kit ligand and supematant media twice weekly until 
week 3. Wells were harvested and the calls phenotyped by an im- 
munomagnetic method (22). Dynabeads M-450 (Dynat) coupled 
with a mAb against CD3 (38,1; kindly provided byJ. A. Hansen, 
Fred Hutchinson's  Cancer Research Center,  Seattle,  WA) were 
selected for detection ofT lymphocytes in the cultures. Wells were 
determined positive for T lymphocytes when >5% of the cells made 
rosettes with more than five beads and the rosetting cells were small 
lymphoid cells. Based on Taswell's equation, the frequency of T lym- 
phocyte progenitors was calculated  (23). 
Statistics.  The growth abilities of CD34 § cells in the absence 
and presence of rmc-kit ligand were compared using the Student's 
t test for paired observations. 
Results 
Characterization  of Isolated  CD34 + Cells.  The immuno- 
magnetically isolated cells contained >90%  CD34 § cells in 
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cytometry-sorted cells contained >98%  CD34 + cells in all 
experiments.  Cells expressing CD3 surface molecules could 
not be detected by flow cytometry (Fig.  1), and neither could 
cells expressing  CD4  or CD8  molecules (not  shown). 
Preparation of  an Adherent Layer of T~mic Stromal Cells  The 
eluted cells were enriched for thymic stromal cells as judged 
by the presence of thymus rosette--forming cells. During cul- 
ture of the eluted cells for 6-8 d, they developed a confluent, 
adherent cell layer. The adherent cell layer contained "~20% 
cells of epitheloid morphology reactive with the TE-15 mAb 
and ~80%  cells of fibroblastoid morphology reactive with 
the TE-7 mAb. 
Growth Ability.  The growth ability of CD34 + cells on 
adherent thymic stromal cells in the absence and presence of 
rmc-kit ligand are shown in Fig. 2. Cell multiplication was 
significantly enhanced by rmc-kit ligand:  from an 8- to 42- 
fold increase in cell number O~ <0.03) after 28 d in culture. 
The  interexperimental  variations  were  large.  A  decrease 
in  number  of nonadherent  cells  was observed when  non- 
CD34 + bone marrow cells, CD4 + T lymphocytes, or CD8 + 
T  lymphocytes were cultured  for 28 d  on thyrnic  stromal 
cells.  This was also the case when  CD34 § cells were cul- 
tured on adherent cells prepared from the MRC-5 cell line, 
the Hep-2 cell line, or aUogeneic peripheral blood monocytes, 
or  together  with  allogeneic  EB blasts.  Opposed  to  non- 
CD34 § bone marrow cells and PBMC, no proliferative re- 
sponse was demonstrated when CD34 § cells were cultured 
in the presence of PHA, rlL-2, and irradiated allogeneic PBMC 
(data not  shown). 
Characterization of Cultured Cells.  The  progeny  of the 
purified CD34 § sCD3 - CD4- CD8 -  cells were analyzed in 
flow cytometry for cell size,  granularity,  and expression of 
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Figure  1.  Characteristics  of" 
isolated CD34 § cells. The light 
scatter  profile  (A)  defines  two 
populations: a "lymphocyte" gate 
and another gate comprising cells 
with a wide range of cell size and 
granularity. The two-color cyto- 
gram (B) illustrates that no de- 
tectable  mature T  lymphocytes 
(sCD3 +)  were  detected  among 
isolated CD34 + cells. 
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The growth ability of CD34 + cells. The cells were cultured 
on thymic stromal cells in the absence  (-) or presence (+) ofrmc-kit ligand. 
Cell multiplication is presented as results of individual experiments (circles) 
and as mean values of all experiments (Mrs). At day 28 the enhancement 
of cell multiplication accomplished by rmc-kit ligand reached statistical 
significance (p <0.03, Students  t test, paired observations). 
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Figure 3.  Characteristics of cultured cells. A representative light scatter 
profile of cultured cells where R1 defines small, agranular cells (the "lym- 
phocyte" gate), R2 defines cells with intermediate size containing no or 
a few granules, and R3 defines large cells, heavily granulated. 
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14 and 28 d in culture. Fig. 3 shows the results of a represen- 
tative analysis of size and granularity of the cells. A  popula- 
tion of cells (R1) is discernible with relatively low light scatter 
signals  characteristic  of agranular  lymphoid cells,  and  two 
larger populations  are discernible  (R2 and R3) with inter- 
mediate and high light scatter signals compatible with cells 
of intermediate size with no or a few cytoplasmic granules 
and  large cells heavily granulated,  respectively. 
Table i  shows the relative number of cells expressing CD34- 
and T lymphocyte-associated surface molecules of the progeny 
of the  CD34+sCD3-CD4-CD8  -  cells  after  28  d  in  cul- 
ture.  Apart  from  a  slightly  higher  relative  number  of 
CD34 §  cells  and  CD4+CD8 +  cells  after  14  d  than  after 
28 d, there were no differences between the relative numbers 
of cells expressing the different  surface molecules  analyzed 
after 14 and 28 d. CD34 expression was mainly confined to 
cells in the R2  fraction (Fig.  3  and Table 1).  On  the other 
hand, cells expressing the CD2, CD7, CD3, CD4, and CD8 
molecules were mainly confined to the R1 fraction (Fig.  4 
and Table 1).  The majority of sCD3 §  cells in K1 fraction 
coexpressed TCK or~f3 (Fig. 4). The low numbers of CD4 + 
CD8 § cells cannot account for the high numbers of sCD3 § 
TCR  ot/B + cells demonstrated  after culture  (Fig.  5, B,  C, 
and E).  Although  not demonstrated in a triple-color cyto- 
gram,  most  if not  all  CD4 +  and  CD8 +  cells  had  to  be 
Table  1.  Relative  Number of Cells Expressing  Different Cell Surface Markers after 28 d in Culture 
Characteristics  of plated cells 
CD34-pos.  cells 
CD34 § cells depleted 
for CD4,8,19 
Exp.  Marker  RI*  R2*  R1  R2 
c-kit ligand  added 
to CD34 + ceUs 
K1  R2 
% 
1  CD34  1  3  1  4  1  4 
2  CD34  1  3  1  2  1  2 
3  CD34  1  7  nt*  nt  1  9 
4  CD34  nt  nt  2  5  nt  nt 
1  CD2  21  2  12  1  6  1 
2  CD2  56  1  54  1  48  4 
3  CD2  22  4  nt  nt  18  4 
4  CD2  nt  nt  38  3  nt  nt 
1  CD7  15  2  8  2  6  1 
2  CD7  61  2  40  1  62  4 
3  CD7  20  5  nt  nt  17  5 
4  CD7  nt  nt  37  3  nt  nt 
1  CD3  20  3  12  2  10  2 
2  CD3  61  1  52  3  56  4 
3  CD3  29  5  nt  nt  26  6 
1  CD4  9  1  9  1  9  <1 
2  CD4  16  1  13  1  20  4 
3  CD4  4  1  nt  nt  10  1 
4  CD4  nt  nt  7  <1  nt  nt 
1  CD8  13  2  9  1  2  <1 
2  CD8  22  1  24  1  20  1 
3  CD8  15  2  nt  nt  10  2 
4  CD8  nt  nt  33  3  nt  nt 
* R1 and K2 refer to regions defined in Fig. 
* nt, not  tested. 
3. 
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Figure 4.  Phenotypic  characterization  of 
cultured cells. Representative two-color cyto- 
grams with a negative control (/).  Cells ex- 
pressing the T  lymphocyte-associated  CD7, 
CD2, and CD3 surfaces  molecules were mainly 
located in the lymphocyte  gate, R1, whereas 
cells expressing  CD34 surface  molecules  were 
confined to R2 (A-F). A major part of the 
CD3 + cells expressed TCK ~//3 (G). All cells 
in the lymphocyte  gate expressed HLA-A2  +, 
i.e., they  are of  bone marrow  donor  HLA type 
(bone marrow donor HLA-A2  + and thymus 
donor HLA-A2-) (H). 
sCD3+TCK ol//3 + . A certain number of cells coexpressed 
the CD4 and CD8 molecules. Data illustrated in Fig. 5 sug- 
gest that the relative number of CD4+CD8 + cells decreased 
from days 14 to 28. To exclude that the few CD4§  + 
cells observed were actually doublets of single-positive cells, 
light scatter properties (i.e., size) of the double-positive cells 
were compared with single-positive  cells. CD4+CD8 + cells 
were exclusively confined to R1, and no differences in size 
between single- and double-positive cells were demonstrated, 
excluding the CD4+CD8 + cells to be doublets.  Further- 
more, dots compatible with CD4 +  CD4 + or CD8 § CD8 + 
doublets could not be demonstrated. A  major part of the 
cells in R2 and R3 fractions could be shown to belong to 
the myeloid lineage by detection of cells expressing CD13 
and CD14 molecules (data not shown). 
There were no differences in distribution of T lymphocyte- 
associated markers whether the progeny were derived from 
CD34 +  cells,  CD34 §  cells  after CD19,  CD4,  and CD8 
depletion, or CD34 + cells cultured in the absence or pres- 
ence of rmc-kit ligand. 
The T lymphocytes emerging after culture could be demon- 
strated to be of bone marrow donor origin by coexpression 
of bone marrow donor-specific HLA or blood group mole- 
cules  and sCD3 (Fig.  4). 
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T  Lymphocyte Progenitors.  A  minor  proportion  of 
CD34+sCD3-CD4-CD8 -  cells was found to coexpress the 
CD2  and/or CD7  molecule (1-2%)  (Fig.  6).  When cul- 
tured in bulk, these subsets  gave rise to lymphoid cells of 
T  lymphocyte lineage just like unfractionated CD34 + cells 
(Figs.  4  and 5).  To examine whether T  lymphocyte pre- 
cursors  were  exclusively  confined  to  the  CD34+CD2 +, 
CD34+CD7 §  and CD34+CD2§  +  subsets,  CD34 + 
CD2-, CD34 § CD7-, and CD34 § CD2- CD7-  cells were 
cultured under the same conditions. The results of these ex- 
periments dearly demonstrate that even CD34 § cells devoid 
of the T  lymphoid markers  CD2  and/or CD7 contained 
T  lymphocyte  progenitors with the ability to proliferate and 
differentiate into T  lympbocytes when cultured on thymic 
stroma in vitro. However, apart from giving rise to T lym- 
phocyte  differentiation, both  CD34+CD2 §  and  CD34 § 
CD7 + cells (and the other subsets  studied) also contained 
progenitors able to differentiate into the myeloid lineage, as 
ascertained by detection of cells expressing CD13 and CD14 
after culture (data not shown). 
To examine whether any of the subsets  of CD34 + cells 
studied in bulk cultures were enriched for T  lymphocyte 
precursors,  limiting dilution analyses were performed. The 
precursor frequency of CD34+CD2 + cells was found to be A  Rll  RI 
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Figure  5.  Phenotypic  characterization  of 
cultured CD34 + cells and subsets of CD34 + 
cells. (B and C) Representative two-color cyto- 
grams of cultured CD34 + cells. At day 14 (/3) 
the presence of CD4+CD8 § cells are clearly 
detectable,  whereas  at  day  28  (C')  double- 
positive cells are hardly detectable. (D--F) Rep- 
resentative two-color cytograms of cultured 
CD34+CD7 + cells.  Similar cytograms were 
obtained  from  cultured  CD34+CD2 +, 
CD34+CD2+CD7+,  CD34+CD7 -, CD34 + 
CD2-,  and  CD34+CD2-CD7 -  cells  (not 
shown)￿9 (A) Negative control. 
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Figure  6.  Characteristics  of 
CD34+CD2 +  and  CD34 + 
CD7 + cells. Representative two- 
color cytograms illustrating the 
presence of CD34 +  cells  coex- 
pressing CD2 or CD7  (1-2%). 
The sort gates are also indicated. 
1:13; CD34§  -  cells, 1:18; CD34+CD7 + cells, 1:9; and 
CD34+CD7 -  cells, 1:8. Accordingly, none of the subset in- 
vestigated  were  found  to  be  enriched  for  T  lymphocyte 
precursors. However, given the level of progenitors revealed 
by the limiting  dilution  analyses,  contaminating  mature T 
lymphocytes, <1% according to flow cytometry, cannot ac- 
count for appearance  of T  lymphocytes after culture. 
Discussion 
T lymphopoiesis from human fetal hematopoietic stem ceils 
has been demonstrated in vivo in the Thy SCID-hu mouse 
model  (15-17).  Furthermore,  T  lymphopoiesis  from  fetal 
human  CD10 + bone marrow cells and from mouse hema- 
topoietic stem cells  has been achieved  in vitro (24,  25).  T 
lymphopoiesis from adult human prethymic CD34 + bone 
marrow cells has been demonstrated neither in vivo nor in 
vitro. The present study demonstrates that T lymphopoiesis 
from  adult  human  CD34 + bone marrow  cells  can be ac- 
complished in vitro. After culture of CD34+sCD3-CD4 - 
CD8-  cells for  14 and 28 d  on allogeneic thymic stromal 
cells, cells of bone marrow donor origin with characteristics 
of lymphoid cells expressing the phenotype of mature T lym- 
phocytes were demonstrated. 
It was necessary to exclude the possibility that the purified 
CD34 + cells contained mature T  lymphocytes, the expan- 
sion of which could account for the T lymphocytes demon- 
strated.  We are confident that  this was not the case. First, 
no mature T  lymphocytes (sCD3 + cells)  were detected by 
flow  cytometric  analyses  of purified  CD34 +  cells￿9 Con- 
taminating  cells  were  almost  exclusively  small  agranular 
cells with the phenotype of mature B lymphocytes (CD34- 
CD19+CD37 +)  (19,  26).  Second,  culture  of non-CD34 § 
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ture T lymphocytes, did not result in any cell multiplication, 
nor did cultures of CD4 + nor CD8 + T lymphoeytes. Third, 
CD34 + cells did not proliferate after stimulation with irradi- 
ated allogeneic PBMC, PHA, and rlL-2. In addition, we have 
previously demonstrated lack of generation of cells expressing 
T lymphocyte-restricted markers after stimulation of purified 
CD34 + cells  with  PHA and rlL-2  (27).  This  is in  accor- 
dance  with  the  finding  that  CD7§  -  human 
thymic and bone marrow cells do not respond to PHA and/or 
rlL-2 (28, 29). Fourth,  after depletion with mAbs against 
CD4CD8  and CD19CD34 + cells still  gave rise to T  lym- 
phocytes. Fifth, the finding of CD4 +  CD8 + cells cannot be 
explained by contamination of mature T lymphocytes among 
the  purified  CD34 §  cells.  Last,  limiting  dilution  analyses 
demonstrated T  lymphocyte precursor frequency of 1:8-18 
in  sorted  CD34 §  cells.  Thus,  outgrowth  of  rare  con- 
taminating mature T  lymphocytes, <1%  according to flow 
cytometry, cannot account for the appearance of CD4 + and 
CD8 + cells  after culture. 
We have presented evidence that when cultured on thymic 
stroma,  CD34 §  human bone marrow cells  proliferate  and 
differentiate along the T  lymphoid lineage.  It might be ar- 
gued  that  the  single-positive  CD4 +  and  CD8 +  cells  ob- 
served after culture could correspond to immature  single- 
positive (i.e.,  preCD4 + CD8 +) cells and not mature CD4 + 
and  CD8 + cells.  In  the  presence  of IL-7,  highly  purified 
human triple-negative thymocytes can proliferate and differ- 
entiate to express CD4 and/or CD8(ot +/3-).  These cells, 
which remain CD3-,  are thought  to precede the common 
cortical double-positive thymocytes that  are CD31~  + 
CDSot+/3 +  (29).  In  our  study,  the  demonstration  of 
CD3bnghtTCR c~/3 § cells  cannot  be accounted for by the 
low  number  of CD4+CD8 §  cells  detected.  Accordingly, 
most,  if  not  all,  CD4 +  and  CD8 +  cells  have  to  be 
CD3+TCR oe/3 + . Based on this,  we are entitled to state 
that CD34 § adult human bone marrow cells when cultured 
on  thymic  stroma  possess  the  ability  to  proliferate  and 
differentiate  into  mature  CD4 +CD3 +TCR  c~/3 +  and 
CD8 +CD3 § TCR  ce/3 +  T  lymphocytes.  The  functional 
ability of these CD4 + and CD8 + T lymphocytes will be ad- 
dressed in ongoing  studies. 
It is generally accepted that development of T  lympho- 
cytes from early thymocytes (sCD3- CD4-CD8-)  involves 
a  stage  of  CD4+CD8 +  cells  preceding  the  appearance 
of  sCD3+CD4 +  and  sCD3+CD8 +  T  lymphocytes. 
CD4 + CD8 + cells were present  at  day 14,  but  they were 
hardly detectable at day 28. This suggests that maturation 
to sCD3 +  CD4 + and sCD3 +  CD8 + lymphocytes took place 
through  an intermediate  stage of CD4 +  CD8 + ceils in this 
in vitro  assay as well. 
We found that a large majority of T lymphocytes devdoping 
when adult human CD34 + bone marrow cells were cultured 
on thymic stroma expressed TCR or/3.  This is in contrast 
to  previous  reports  that  postnatal  sCD3-CD4-CD8- 
thymic T  lymphocyte precursors develop nearly exclusively 
into TCR q,/~+  cells in cultures without feeder cells  (30). 
However, fetal sCD3-CD4-CD8-  thymic T  lymphocyte 
precursors develop into TCR ot/~ § cells (31,  32).  Human 
T  lymphocytes found in the peripheral blood of SCID-hu 
(fetal thymus and liver) mice express TCR a/3 (33). Finally, 
hematopoietic stem cells  in  the Go phase from adult mice 
differentiate into T  lymphocytes expressing TCR 3  chains 
in an in vitro organ culture assay with fetal thymic tissue 
(25). Taken together with the present results, this suggests 
that  thymic stroma is necessary for the development of T 
lymphocytes expressing TCR o#3 from postnatal progen- 
itors.  This  notion  is  further  supported  by another  report 
showing that thymic stromal cells are required for the devel- 
opment of both or//3 and 3d/$ T lymphocytes from postnatal 
CD7 +  CD45 +  CD1 - CD2- CD3- CD4- CD8- early thymo- 
cytes (34). In previous studies where T lymphopoiesis from 
hematopoietic stem cells was achieved, the three-dimensional 
structure of the thymic microenvironment  was maintained 
(16,  17,  25).  Our  studies confirm  the necessity of thymic 
stroma, but the maintenance of the three-dimensional struc- 
ture is not always necessary.  In the absence of thymic stroma 
we were not able to obtain T lymphocyte differentiation when 
CD34 + cells were cultured in the presence of several com- 
binations of growth factors (rlL-1, rlL-2, rlL-3, rlL-7, GM- 
CSF, and rmc-kit ligand) or supernatant from thymic stromal 
cells (27, Steen, R., L. Mcrkrid,  G. E. Tjcnnijord,  and T. 
Egeland, manuscript submitted for publication, and unpub- 
lished observations). 
Human  CD34 +  cells  are phenotypically  heterogeneous 
with  subsets  coexpressing  lineage-specific  markers.  CD7 
and CD2 are believed to be expressed by prethymic pre-T 
cells  (7,  11,  12,  31,  35,  36).  Therefore,  the  ability 
of  CD34+CD2 +,  CD34+CD7 +,  CD34+CD2+CD7+, 
CD34+CD2 -,  CD34§  -,  and  CD34+CD2-CD7 - 
bone marrow cells to differentiate into T  lymphocytes was 
studied in the same assay. Progenitors able to support T lym- 
phophoiesis in vitro were found in all of these subsets. Fur- 
thermore, limiting dilution analyses did not demonstrate en- 
richment of T lymphocyte precursors in any of these subsets. 
The inability to demonstrate an enrichment for T  lympho- 
cyte precursors among different subsets of CD34 + cells may 
reflect thymus-dependent  negative selection and apoptosis. 
This may be the rate-limiting step even in this in vitro assay 
and may preclude the finding of a possible difference in T 
lymphocyte precursor frequency of the subsets studied.  In 
vivo, surface molecules like leukocyte endothelial cell adhe- 
sion  molecule  1  (LECAM-1)  known  to  be  expressed  by 
CD34+CD2+CD7 + bone marrow cells, may be involved in 
homing of these cells to thymus (12). The concept of homing 
is bypassed in this in vitro assay, and this as well as other 
culture-associated phenomena may account for our inability 
to demonstrate a difference in precursor frequency between 
different  subsets of CD34 + cells. 
CD34+CD7§  and  CD34+CD2 § 
sCD3-CD4-CD8-  cells as well as the other subsets studied 
were multipotent  since they were capable of giving rise to 
myeloid progeny. This corresponds with the demonstration 
of differentiation into nonlymphoid lineages of human thymic 
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IL-3, Epo, G-CSF, M-CSF, GM-CSF, and factors produced 
by thymic epithdial  (TE) cells  (37). 
Both purified native and rc-kit ligand show synergistic ac- 
tions with other factors on whole bone marrow and isolated 
CD34 + human cells such as IL-3, IL-1, IL-6, G-CSF, GM- 
CSF, and Epo in various assays (38-40,  and Steen,  R.,  L. 
Mcrkrid, G. E. Tjcnnfjord, and T. Egeland, manuscript sub- 
mitted for publication). The results presented here show that 
rmc-kit ligand  strongly potentiated  the cell multiplication 
in this assay without changing the phenotypic profile of the 
progeny. This supports the view that the synergistic effect 
of rmc-kit ligand on growth factors also includes growth factors 
neccessary for T  lymphopoiesis. 
In  the  present  study  we  show  that  purified  CD34 + 
sCD3-CD4-CD8-  bone marrow cells from healthy adults 
contained  progenitors  with  the  ability  to  proliferate  and 
differentiate into CD3 + CD4 + or CD3 +  CD8 + T  lympho- 
cytes expressing TCR ot//~ in vitro. The presence of thymic 
stromal cells seemed to be a prerequisite for T lymphopoiesis 
to be accomplished from bone marrow progenitors.  T lym- 
phocyte progenitors were found both among CD34 + cells 
expressing CD2 or CD7 surface markers and CD34 + cells 
devoid of these markers. Furthermore, c-kit ligand enhanced 
T  lymphopoiesis. 
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